200 related articles for article (PubMed ID: 8661391)
21. Innate and acquired immunity to herpes simplex virus type 1.
Halford WP; Veress LA; Gebhardt BM; Carr DJ
Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
[TBL] [Abstract][Full Text] [Related]
22. Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain.
Geiss BJ; Smith TJ; Leib DA; Morrison LA
J Virol; 2000 Dec; 74(23):11137-44. PubMed ID: 11070010
[TBL] [Abstract][Full Text] [Related]
23. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge.
Morrison LA; Da Costa XJ; Knipe DM
Virology; 1998 Mar; 243(1):178-87. PubMed ID: 9527927
[TBL] [Abstract][Full Text] [Related]
24. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
25. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
27. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.
Ghiasi H; Cai S; Slanina SM; Perng GC; Nesburn AB; Wechsler SL
J Infect Dis; 1999 May; 179(5):1086-93. PubMed ID: 10191208
[TBL] [Abstract][Full Text] [Related]
28. Effect of acyclovir on thermal stress-induced herpesvirus reactivation.
Gebhardt BM; Kaufman HE; Hill JM
Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960
[TBL] [Abstract][Full Text] [Related]
29. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
Ellison AR; Yang L; Voytek C; Margolis TP
Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
[TBL] [Abstract][Full Text] [Related]
30. Immunisation of Balb/c mice with severely attenuated murine cytomegalovirus mutants induces protective cellular and humoral immunity.
Morley PJ; Ertl P; Sweet C
J Med Virol; 2002 Jun; 67(2):187-99. PubMed ID: 11992579
[TBL] [Abstract][Full Text] [Related]
31. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus type 1 VP26 is not essential for replication in cell culture but influences production of infectious virus in the nervous system of infected mice.
Desai P; DeLuca NA; Person S
Virology; 1998 Jul; 247(1):115-24. PubMed ID: 9683577
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis.
Branco FJ; Fraser NW
J Virol; 2005 Jul; 79(14):9019-25. PubMed ID: 15994795
[TBL] [Abstract][Full Text] [Related]
34. Differential importance of highly conserved residues in UL24 for herpes simplex virus 1 replication in vivo and reactivation.
Leiva-Torres GA; Rochette PA; Pearson A
J Gen Virol; 2010 May; 91(Pt 5):1109-16. PubMed ID: 20071482
[TBL] [Abstract][Full Text] [Related]
35. Functional hierarchy of herpes simplex virus type-1 membrane proteins in corneal infection and virus transmission to ganglionic neurons.
Kim IJ; Saied AA; Chouljenko VN; Subramanian R; Kousoulas KG
Curr Eye Res; 2014 Dec; 39(12):1169-77. PubMed ID: 24749493
[TBL] [Abstract][Full Text] [Related]
36. Viral replication is required for induction of ocular immunopathology by herpes simplex virus.
Babu JS; Thomas J; Kanangat S; Morrison LA; Knipe DM; Rouse BT
J Virol; 1996 Jan; 70(1):101-7. PubMed ID: 8523513
[TBL] [Abstract][Full Text] [Related]
37. Effect of immunization on herpes simplex virus type 1 latent infection in the trigeminal ganglion.
Kramer M; Riley J; Spoering A; Coen D; Knipe D
Curr Eye Res; 2003; 26(3-4):185-94. PubMed ID: 12815546
[TBL] [Abstract][Full Text] [Related]
38. The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.
Augustinova H; Hoeller D; Yao F
J Virol; 2004 Jun; 78(11):5756-65. PubMed ID: 15140973
[TBL] [Abstract][Full Text] [Related]
39. In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector.
Speck PG; Efstathiou S; Minson AC
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2563-8. PubMed ID: 8887491
[TBL] [Abstract][Full Text] [Related]
40. Herpes simplex virus glycoprotein D. Protective immunity against murine herpetic keratitis.
Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):411-8. PubMed ID: 2318582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
